Altium Capital Management Lp Top Holdings and 13F Report (2025) About Altium Capital Management LpInvestment ActivityAltium Capital Management Lp has $43.79 million in total holdings as of March 31, 2025.Altium Capital Management Lp owns shares of 23 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 22.27% of the portfolio was purchased this quarter.About 690.03% of the portfolio was sold this quarter.This quarter, Altium Capital Management Lp has purchased 63 new stocks and bought additional shares in 0 stocks.Altium Capital Management Lp sold shares of 17 stocks and completely divested from 46 stocks this quarter.Largest Holdings Zevra Therapeutics $9,642,124Alnylam Pharmaceuticals $6,750,500Evolus $3,563,202Xtant Medical $3,408,909AVADEL PHARMACEUTICALS PLC $3,281,796 Largest New Holdings this Quarter 02043Q107 - Alnylam Pharmaceuticals $6,750,500 Holding67091J602 - LOGICMARK INC $1,946,849 Holding82003F200 - SHARPS TECHNOLOGY INC $560,250 Holding36151G600 - INTELLIGENT BIO SOLUTIONS IN $214,923 Holding48576U205 - KARYOPHARM THERAPEUTICS INC $184,505 Holding Largest Purchases this Quarter Alnylam Pharmaceuticals 25,000 shares (about $6.75M)LOGICMARK INC 98,325,683 shares (about $1.95M)SHARPS TECHNOLOGY INC 18,737,471 shares (about $560.25K)INTELLIGENT BIO SOLUTIONS IN 149,252 shares (about $214.92K)KARYOPHARM THERAPEUTICS INC 49,333 shares (about $184.51K) Largest Sales this Quarter Xenon Pharmaceuticals 227,749 shares (about $7.64M)Evolus 388,807 shares (about $4.68M)Zevra Therapeutics 562,667 shares (about $4.21M)Rezolute 1,390,051 shares (about $4.03M)ANTERIS TECHNOLOGIES GLOBAL 568,411 shares (about $2.07M) Sector Allocation Over TimeMap of 500 Largest Holdings ofAltium Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorZVRAZevra Therapeutics$9,642,124$4,214,376 ▼-30.4%1,287,33322.0%MedicalALNYAlnylam Pharmaceuticals$6,750,500$6,750,500 ▲New Holding25,00015.4%MedicalEOLSEvolus$3,563,202$4,677,348 ▼-56.8%296,1938.1%MedicalXTNTXtant Medical$3,408,909$76,335 ▼-2.2%7,252,9987.8%MedicalAVADEL PHARMACEUTICALS PLC$3,281,796$261,084 ▼-7.4%419,1317.5%COM SHSXENEXenon Pharmaceuticals$2,336,791$7,640,979 ▼-76.6%69,6515.3%MedicalCONTINEUM THERAPEUTICS INC$2,120,922$210,398 ▼-9.0%303,8574.8%CL APROFProfound Medical$2,098,628$724,072 ▼-25.7%360,5894.8%MedicalLOGICMARK INC$1,946,849$1,946,849 ▲New Holding98,325,6834.4%COM NEWEPIXESSA Pharma$1,659,583$596,657 ▼-26.4%1,050,3693.8%MedicalSKYE BIOSCIENCE INC$1,438,735$372,275 ▼-20.6%904,8653.3%COM NEWALPHA COGNITION INC$897,725$493,775 ▼-35.5%177,4162.1%COM NEWRZLTRezolute$881,452$4,031,147 ▼-82.1%303,9492.0%MedicalNKTRNektar Therapeutics$714,938$1,325,063 ▼-65.0%1,051,3791.6%MedicalANTERIS TECHNOLOGIES GLOBAL$613,664$2,069,016 ▼-77.1%168,5891.4%COMLRMRLarimar Therapeutics$587,389$1,349,762 ▼-69.7%273,2041.3%MedicalSHARPS TECHNOLOGY INC$560,250$560,250 ▲New Holding18,737,4711.3%COM NEWPMNProMIS Neurosciences$399,389$4,971 ▼-1.2%574,2480.9%MedicalNVNOenVVeno Medical$324,163$491,136 ▼-60.2%123,2560.7%MedicalINTELLIGENT BIO SOLUTIONS IN$214,923$214,923 ▲New Holding149,2520.5%COMKARYOPHARM THERAPEUTICS INC$184,505$184,505 ▲New Holding49,3330.4%COM NEWSUNSHINE BIOPHARMA INC$96,390$96,390 ▲New Holding50,4660.2%COMBETTER CHOICE CO INC$67,052$136,696 ▼-67.1%38,9840.2%COM NEWESTAEstablishment Labs$0$27,872,350 ▼-100.0%00.0%MedicalADMAADMA Biologics$0$23,924,250 ▼-100.0%00.0%MedicalVERAVera Therapeutics$0$18,269,280 ▼-100.0%00.0%MedicalSRPTSarepta Therapeutics$0$15,441,930 ▼-100.0%00.0%MedicalSRRKScholar Rock$0$12,966,000 ▼-100.0%00.0%MedicalEWEdwards Lifesciences$0$12,214,950 ▼-100.0%00.0%MedicalSLNOSoleno Therapeutics$0$11,237,500 ▼-100.0%00.0%MedicalCAPRCapricor Therapeutics$0$9,853,200 ▼-100.0%00.0%MedicalRXSTRxSight$0$9,798,300 ▼-100.0%00.0%MedicalMMSIMerit Medical Systems$0$9,672,000 ▼-100.0%00.0%MedicalBHVNBiohaven$0$9,337,500 ▼-100.0%00.0%MedicalINSMInsmed$0$9,113,280 ▼-100.0%00.0%MedicalITCIIntra-Cellular Therapies$0$6,264,000 ▼-100.0%00.0%MedicalARGXargenx$0$6,150,000 ▼-100.0%00.0%MedicalGKOSGlaukos$0$5,997,600 ▼-100.0%00.0%MedicalRMDResMed$0$5,945,940 ▼-100.0%00.0%MedicalVKTXViking Therapeutics$0$5,875,040 ▼-100.0%00.0%MedicalEXASExact Sciences$0$5,619,000 ▼-100.0%00.0%MedicalLUNGPulmonx$0$5,533,850 ▼-100.0%00.0%MedicalCMPSCOMPASS Pathways$0$5,384,232 ▼-100.0%00.0%MedicalCPRXCatalyst Pharmaceuticals$0$5,321,850 ▼-100.0%00.0%MedicalSNDXSyndax Pharmaceuticals$0$4,891,400 ▼-100.0%00.0%MedicalSVRASavara$0$4,847,530 ▼-100.0%00.0%MedicalCRBPCorbus Pharmaceuticals$0$4,543,000 ▼-100.0%00.0%MedicalARWRArrowhead Pharmaceuticals$0$4,328,832 ▼-100.0%00.0%MedicalANABAnaptysBio$0$2,972,724 ▼-100.0%00.0%MedicalORICORIC Pharmaceuticals$0$2,864,850 ▼-100.0%00.0%MedicalTGTXTG Therapeutics$0$2,859,500 ▼-100.0%00.0%MedicalKROSKeros Therapeutics$0$2,770,250 ▼-100.0%00.0%MedicalIBRXImmunityBio$0$2,713,600 ▼-100.0%00.0%MedicalLEXEO THERAPEUTICS INC$0$2,664,900 ▼-100.0%00.0%COMTERNTerns Pharmaceuticals$0$2,631,500 ▼-100.0%00.0%MedicalRVMDRevolution Medicines$0$2,624,400 ▼-100.0%00.0%MedicalATECAlphatec$0$2,428,679 ▼-100.0%00.0%MedicalONKURE THERAPEUTICS INC$0$1,878,120 ▼-100.0%00.0%COM CL APRQRProQR Therapeutics$0$1,523,750 ▼-100.0%00.0%MedicalVERUVeru$0$1,319,561 ▼-100.0%00.0%MedicalUNCYUnicycive Therapeutics$0$1,169,857 ▼-100.0%00.0%MedicalBCYCBicycle Therapeutics$0$564,928 ▼-100.0%00.0%MedicalFULCFulcrum Therapeutics$0$525,516 ▼-100.0%00.0%MedicalKPTIKaryopharm Therapeutics$0$500,462 ▼-100.0%00.0%MedicalCTMXCytomX Therapeutics$0$481,516 ▼-100.0%00.0%MedicalPERSPECTIVE THERAPEUTICS INC$0$294,195 ▼-100.0%00.0%COM NEWQUOIN PHARMACEUTICALS LTD$0$183,659 ▼-100.0%00.0%SPONSORED ADSCLRBCellectar Biosciences$0$64,285 ▼-100.0%00.0%MedicalAPLTApplied Therapeutics$0$48,033 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
